IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v15y2018i5p864-d143359.html
   My bibliography  Save this article

Disability-Adjusted Life Years for Cancer in 2010–2014: A Regional Approach in Mexico

Author

Listed:
  • Efrén Murillo-Zamora

    (Unidad de Medicina Familiar No. 19, Instituto Mexicano del Seguro Social, Av. Javier Mina 301, Col. Centro, Colima 28000, Colima, Mexico)

  • Oliver Mendoza-Cano

    (Facultad de Ingeniería Civil, Universidad de Colima, Km. 9.0 Carretera Colima-Coquimatlán, Coquimatlán 28400, Colima, Mexico)

  • Mónica Ríos-Silva

    (Profesora Investigadora Cátedras CONACyT-Universidad de Colima, Centro Universitario de Investigaciones Biomédicas, Colima 28040, Colima, Mexico)

  • Ramón Alberto Sánchez-Piña

    (Center for Health and the Global Environment, Department of Environmental Health, Harvard TH Chan School of Public Health, 401 Park Drive, P.O. Box 15677, 4th Floor West, Suite 415, Boston, MA 02215, USA)

  • Martha Alicia Higareda-Almaraz

    (Jefatura de Servicios de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Álvaro Obregón 184, Col. Centro, Colima 28000, Colima, Mexico)

  • Enrique Higareda-Almaraz

    (Jefatura de Servicios de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Álvaro Obregón 184, Col. Centro, Colima 28000, Colima, Mexico)

  • Agustin Lugo-Radillo

    (CONACYT-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Carretera a San Felipe del Agua, Oaxaca 68020, Oaxaca, Mexico)

Abstract

The disability-adjusted life years (DALYs) were used to estimate the regional (state of Colima, Mexico) cancer burden in 2010–2014. The years of life lost (YLL) were estimated with mortality data and years lived with disability (YLD) using incidence data. The DALYs were calculated as the arithmetic addition of YLL and YLD. Sex and cancer site-specific estimations were made and DALY rates were used to identify the leading causes of disease burden. Data from 2532 deaths were analyzed and, for all malignant tumors combined, 18,712.9 DALYs and 20,243.3 DALYs were estimated in males and females respectively. The overall contribution of YLL in DALY estimates was higher among females (93.7% vs. 87.4%). Age-standardized DALY rates (and 95% confidence intervals, CI) per 100,000 inhabitants were used to rank the leading causes of disease burden and, among males, malignant tumors from the prostate, lower respiratory tract, and colon and rectum accounted the highest rates (45.7, 95% CI 32.7–59.3; 37.6, 95% CI 25.7–49.9; and 25.9, 95% CI 16.0–36.1 DALYs). Breast, cervix uteri, and lower respiratory tract cancer showed the highest burden in females (66.0, 95% CI 50.3–82.4; 44.4, 95% CI 31.5–57.7; and 20.9, 95% CI 12.0–30.0 DALYs). The present study provides an indication of the burden of cancer at the regional level, underscoring the need to expand cancer prevention, screening, and awareness programs, as well as to improve early diagnosis and medical treatment.

Suggested Citation

  • Efrén Murillo-Zamora & Oliver Mendoza-Cano & Mónica Ríos-Silva & Ramón Alberto Sánchez-Piña & Martha Alicia Higareda-Almaraz & Enrique Higareda-Almaraz & Agustin Lugo-Radillo, 2018. "Disability-Adjusted Life Years for Cancer in 2010–2014: A Regional Approach in Mexico," IJERPH, MDPI, vol. 15(5), pages 1-10, April.
    • Handle: RePEc:gam:jijerp:v:15:y:2018:i:5:p:864-:d:143359
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/15/5/864/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/15/5/864/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Grimard, Franque & Laszlo, Sonia & Lim, Wilfredo, 2010. "Health, aging and childhood socio-economic conditions in Mexico," Journal of Health Economics, Elsevier, vol. 29(5), pages 630-640, September.
    2. Mark S. Thompson, 1983. "Health Versus Money," Medical Decision Making, , vol. 3(3), pages 285-297, August.
    3. Howard, David H., 2005. "Life expectancy and the value of early detection," Journal of Health Economics, Elsevier, vol. 24(5), pages 891-906, September.
    4. Brecht Devleesschauwer & Arie Havelaar & Charline Maertens de Noordhout & Juanita Haagsma & Nicolas Praet & Pierre Dorny & Luc Duchateau & Paul Torgerson & Herman Oyen & Niko Speybroeck, 2014. "Calculating disability-adjusted life years to quantify burden of disease," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 59(3), pages 565-569, June.
    5. Hurley, Jeremiah, 2000. "An overview of the normative economics of the health sector," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 2, pages 55-118, Elsevier.
    6. Abraham Mehrez & Amiram Gafni, 1989. "Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents," Medical Decision Making, , vol. 9(2), pages 142-149, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Thinni Nurul Rochmah & Anggun Wulandari & Maznah Dahlui & Ernawaty & Ratna Dwi Wulandari, 2020. "Cost Effectiveness Analysis Using Disability-Adjusted Life Years for Cataract Surgery," IJERPH, MDPI, vol. 17(16), pages 1-9, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Schmid, Andreas, 2007. "Incentive Compatibility and Efficiency in the contractual Insurer-Provider Relationship: Economic Theory and practical Implications: The Case of North Carolina," MPRA Paper 23311, University Library of Munich, Germany, revised 2008.
    2. Fleurbaey, Marc & Schokkaert, Erik, 2009. "Unfair inequalities in health and health care," Journal of Health Economics, Elsevier, vol. 28(1), pages 73-90, January.
    3. Hougaard, Jens Leth & Moreno-Ternero, Juan D. & Østerdal, Lars Peter, 2013. "A new axiomatic approach to the evaluation of population health," Journal of Health Economics, Elsevier, vol. 32(3), pages 515-523.
    4. Carl Lyttkens, 2009. "Why the econometrician is in good spirits: a workshop through the looking glass," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 239-242, July.
    5. Richardson, Jeff & Sinha, Kompal & Iezzi, Angelo & Maxwell, Aimee, 2012. "Maximising health versus sharing: Measuring preferences for the allocation of the health budget," Social Science & Medicine, Elsevier, vol. 75(8), pages 1351-1361.
    6. Diecidue, E. & Schmidt, U. & Wakker, P.P., 2000. "A Theory of the Gambling Effect," Discussion Paper 2000-75, Tilburg University, Center for Economic Research.
    7. Mark Sculpher & Amiram Gafni, 2001. "Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 317-324, June.
    8. Philippe Batifoulier & John Latsis & Jacques Merchiers, 2010. "Les priorités de la prise en charge financière des soins. Une approche par la philosophie du besoin," EconomiX Working Papers 2010-2, University of Paris Nanterre, EconomiX.
    9. Zhao, Junying & Kim, Myongjin & Westbrook, Gabrielle & Bratzler, Dale W, 2022. "A comparative study of COVID-19 emergency funds allocated to the health sector: US, UK, and Canada," Health Policy, Elsevier, vol. 126(6), pages 493-503.
    10. McNamee, Paul, 2007. "What difference does it make? The calculation of QALY gains from health profiles using patient and general population values," Health Policy, Elsevier, vol. 84(2-3), pages 321-331, December.
    11. Olmstead, Todd & Zeckhauser, Richard, 1999. "The menu-setting problem and subsidized prices: drug formulary illustration," Journal of Health Economics, Elsevier, vol. 18(5), pages 523-550, October.
    12. Stolpe, Michael, 2003. "Ressourcen und Ergebnisse der globalen Gesundheitsökonomie: Einführung und Überblick," Kiel Working Papers 1177, Kiel Institute for the World Economy (IfW Kiel).
    13. Hugh Gravelle & Dave Smith, 2001. "Discounting for health effects in cost–benefit and cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 587-599, October.
    14. Krucien, Nicolas & Heidenreich, Sebastian & Gafni, Amiram & Pelletier-Fleury, Nathalie, 2020. "Measuring public preferences in France for potential consequences stemming from re-allocation of healthcare resources," Social Science & Medicine, Elsevier, vol. 246(C).
    15. Jeremiah Hurley & Emmanouil Mentzakis, 2011. "Existence and Magnitude of Health-related Externalities: Evidence from a Choice Experiment," Department of Economics Working Papers 2011-01, McMaster University.
    16. BOUCKAERT, Nicolas & SCHOKKAERT, Erik, 2013. "Differing types of medical prevention appeal to different individuals," LIDAM Discussion Papers CORE 2013038, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    17. Hoel, Michael, 2007. "What should (public) health insurance cover?," Journal of Health Economics, Elsevier, vol. 26(2), pages 251-262, March.
    18. Carmen Herrero Blanco, 2001. "Individual Evidence Of Independence In Health Profiles Evaluation," Working Papers. Serie AD 2001-20, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
    19. Olivier Chanel & Pascale Scapecchi & Jean-Christophe Vergnaud, 2006. "How to correctly assess mortality benefits in public policies," Journal of Environmental Planning and Management, Taylor & Francis Journals, vol. 49(5), pages 759-776.
    20. Bleichrodt, Han, 1997. "Health utility indices and equity considerations," Journal of Health Economics, Elsevier, vol. 16(1), pages 65-91, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:15:y:2018:i:5:p:864-:d:143359. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.